Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Eileen O Reilly
Person

Eileen O Reilly

Tracked across 1 events · 74 articles · First seen May 29, 2026 · Last active Jun 04, 2026

Sentiment
70
Attention
7
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
7 70
Tech
Revolution_Medicines' daraxonrasib extends pancreatic cancer survival
Researchers have reported a significant breakthrough in treating advanced pancreatic cancer with an experimental pill called daraxonrasib, developed by Revolution Medicines. The daily pill nearly doubled the median survival time for patients whose metastatic cancer…
Impact: Eileen O Reilly, a pancreatic cancer specialist at Memorial Sloan Kettering Cancer Center, was the lead author of a paper detailing daraxonrasib's results, providing expert insight into the drug's efficacy and patient adherence.
May 29, 2026 · 74 articles
Key Actions (1)
70 Eileen O Reilly authored paperRevolution_Medicines'...
NEWSDESK
Track Eileen O Reilly live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.